| Literature DB >> 34322083 |
Jing Du1,2,3, Hong Zhu4, Ling Yu1,2, Peiwen Lu1,2,3, Yage Qiu5, Yan Zhou5, Wenwei Cao1,2, Dong Lu1,2, Wei Zhao1,2, Jie Yang1,2, Junfeng Sun4, Qun Xu1,2,3.
Abstract
Objectives: We aim to investigate whether multi-dimensional diffusion tensor imaging (DTI) measures can sensitively identify different cognitive status of cerebral small vessel disease (CSVD) and to explore the underlying pattern of white matter disruption in CSVD.Entities:
Keywords: cerebral small vessel disease; dementia; diffusion tensor imaging; structural network; vascular cognitive impairment
Year: 2021 PMID: 34322083 PMCID: PMC8311001 DOI: 10.3389/fneur.2021.687959
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.003
Demographic and vascular risk factors description.
| Male (%) | 31 (72.1) | 49 (81.7) | 70 (70.7) | 0.289 |
| Age, mean (SD) | 65.74 (4.806) | 65.39 (7.611) | 64.17 (7.057) | 0.353 |
| Education year, mean (SD) | 11.67 (2.741) | 11.42 (3.035) | 10.26 (2.823) | 0.008 |
| Hypercholesterolemia (%) | – | 4 (7.0) | 11 (12.1) | 0.408 |
| Diabetes mellitus (%) | – | 21 (39.6) | 33 (35.9) | 0.722 |
| Hypertension (%) | – | 40 (74.1) | 72 (77.4) | 0.690 |
| Smoking (%) | – | 33 (62.3) | 40 (44.9) | 0.057 |
| Drinking (%) | – | 19 (35.2) | 25 (28.7) | 0.458 |
Data represent number (percentage) and mean (standard deviation) for normally distributed data; SD, standard deviation; p-value < 0.05 was considered to be statistically significant; CSVD, cerebral small vessel disease; VaMCI, CSVD with mild cognitive impairment; NCI, CSVD with no cognitive impairment; NC, normal control;
represents significant difference between NC and VaMCI,
represents significant difference between NCI and VaMCI.
Figure 1Results of group comparison for different cognitive tests. (A–I) One-way ANOVA test was applied to conduct the group comparison of cognitive scores. p-value < 0.05 was considered to be statistically significant, * represents p < 0.05. VaMCI, CSVD with mild cognitive impairment; NCI, CSVD with no cognitive impairment; NC, normal control; MoCA, Montreal Cognitive Assessment; TMT-B, Trail-Making Tests B; SCWT-C, Stroop color word test C; DSS, digital span substitution test; VFT, verbal fluency test; AVLT-4/5, auditory verbal learning test short and long delayed free recall; BNT, Boston Naming Test; Rey-O copy, Rey-Osterrieth Complex Figure Test (copy).
Figure 2Group difference of DTI measures. (A–F) One-way ANOVA test was applied to conduct the group comparison of DTI measures, p-value < 0.05 was considered to be statistically significant. * represents p-value < 0.05 after Bonferroni correction. VaMCI, CSVD with mild cognitive impairment; NCI, CSVD with no cognitive impairment; NC, normal control; FA, mean fractional anisotropy of the skeleton; MD, mean of mean diffusivity of the skeleton; PSMD, peak width of skeletonized mean diffusivity; EGlobal, global efficiency; ELocal, local efficiency.
Correlation between DTI measures and cognition within non-demented CSVD patients.
| MoCA | 0.240 | 0.011 | −0.148 | 0.122 | −0.243 | 0.011 | 0.207 | 0.030 | 0.233 | 0.014 | 0.313 | 0.001 |
| TMT-B | −0.280 | 0.002 | 0.224 | 0.013 | 0.210 | 0.022 | −0.218 | 0.017 | −0.218 | 0.017 | −0.143 | 0.116 |
| SCWT-C | −0.284 | 0.002 | 0.258 | 0.004 | 0.246 | 0.007 | −0.190 | 0.037 | −0.200 | 0.029 | −0.223 | 0.014 |
| DSS | 0.200 | 0.023 | −0.202 | 0.022 | −0.188 | 0.033 | 0.224 | 0.011 | 0.239 | 0.006 | 0.253 | 0.004 |
| VFT | 0.087 | 0.329 | −0.089 | 0.315 | −0.147 | 0.096 | 0.172 | 0.052 | 0.101 | 0.252 | 0.158 | 0.073 |
| AVLT4 | 0.198 | 0.025 | −0.138 | 0.118 | −0.166 | 0.060 | 0.224 | 0.011 | 0.111 | 0.209 | 0.166 | 0.060 |
| AVLT5 | 0.208 | 0.018 | −0.146 | 0.099 | −0.127 | 0.152 | 0.223 | 0.011 | 0.131 | 0.138 | 0.146 | 0.100 |
| Rey-O copy | 0.127 | 0.153 | −0.290 | 0.001 | −0.357 | <0.001 | 0.275 | 0.002 | 0.196 | 0.026 | 0.224 | 0.011 |
| BNT | 0.063 | 0.480 | −0.030 | 0.734 | −0.158 | 0.074 | 0.072 | 0.419 | 0.064 | 0.472 | 0.139 | 0.116 |
FA, mean fractional anisotropy of the skeleton; MD, mean of mean diffusivity of the skeleton; PSMD, peak width of skeletonized mean diffusivity; E;
means p < 0.05.
Figure 3Group comparison results of ROI analysis for 42 white matter tracts. Group comparison of FA and MD on regional white matter tracts. Upper panels show the FA difference between every two groups, and lower panels show the MD results between every two groups. FA, skeletonized fractional anisotropy; MD, skeletonized mean diffusivity, VaMCI, CSVD with mild cognitive impairment; NCI, CSVD with no cognitive impairment; NC, normal control.